510(k) pathway assessment
Review device classification, intended use, product code, regulatory history, and predicate options before the team commits to a submission plan.
Talk to an expert510(K) SUBMISSION CONSULTING
Build a 510(k) submission around the decisions that make it defensible: the right pathway, a clear predicate position, evidence that supports the claim, and a record that holds together under review.
Discuss your 510(k) →
THE WORK BEFORE THE FILE
Most 510(k) delays do not start with one missing document. They begin earlier, when intended use, predicate logic, performance testing, labeling, risk management, and quality records develop on separate tracks. By the time those assumptions meet in the submission, correcting the gaps can cost time, budget, and confidence in the launch plan.
Qualira helps medical-device teams bring those decisions into one workable strategy. The goal is not simply to assemble a file. It is to create a clear, proportionate regulatory case for the device, with the evidence and documentation needed to support it.
WHERE QUALIRA HELPS
Review device classification, intended use, product code, regulatory history, and predicate options before the team commits to a submission plan.
Connect substantial equivalence reasoning to the performance, safety, software, human factors, biocompatibility, sterilization, and other evidence the device needs.
Bring the device description, comparisons, test reports, risk documentation, labeling, and summaries into a coherent, review-ready story.
Provide a focused readiness assessment before filing or added senior support when FDA questions, device changes, or timing pressure reshape the work.
FROM STRATEGY TO SUBMISSION
A 510(k) needs more than a predicate device in the same category. The submission has to explain why the subject device and predicate have the appropriate intended use, technological comparison, and supporting evidence to reach a defensible conclusion. That reasoning affects how the team scopes testing, frames device differences, writes claims, and presents the data.
Qualira begins with the decisions that drive the rest of the program. For an early-stage device, that can mean testing whether the proposed predicate and intended use are truly aligned before verification activities are fixed. For an active program, it can mean identifying where the evidence package, risk files, labeling, and technical documentation have drifted apart and resolving the issues before they become review questions.
The work then moves into disciplined submission development. Strong content makes the logic easy to follow across the device description, substantial equivalence discussion, testing summaries, standards declarations, and supporting records. The reviewer should be able to see how each element supports the same conclusion, without having to reconstruct the story from disconnected source material.
WHAT A STRONG ENGAGEMENT CLARIFIES
Teams often have the technical details available but need help deciding which facts matter most to the submission position. The useful question is not, “What documents do we have?” It is, “Does the complete record support the device we intend to bring to market?”
A plausible predicate is not always a durable pathway. Qualira helps teams evaluate intended use, technology differences, available evidence, and regulatory history before they invest heavily in a strategy that may not hold up.
Testing needs vary with the device and its claims. A focused evidence plan helps the team understand where bench performance, software documentation, electrical safety, biocompatibility, sterilization, usability, or clinical information is needed, and where it is not.
Predicate comparisons, risk analyses, verification records, labeling, and test reports need to reinforce the same regulatory rationale. Qualira helps expose conflicts early and turn complex inputs into a submission that reads clearly and consistently.
Additional information requests are easier to manage when the team understands the gap behind the question. Qualira can help organize the response, coordinate technical contributors, and keep the answer tied to the original submission strategy.
A DECISION-LED APPROACH
510(k) work can look straightforward until small decisions begin to compound. A device difference changes a testing assumption. A revised claim affects labeling. A risk-control decision has to be supported across the design history, verification records, and submission content. The point of experienced support is to keep those decisions visible and connected while the program still has room to respond.
Qualira works alongside internal regulatory, engineering, quality, clinical, and leadership teams. Some engagements call for guidance from the first pathway question through filing. Others need a targeted assessment, senior review, or focused help when a key assumption has changed. The support should fit the decision in front of the program, not force a one-size-fits-all process.
That is especially valuable when the product is moving quickly. A compressed schedule does not remove the need for sound predicate reasoning or complete evidence. It makes clear priorities, accountable owners, and early escalation more important, so the team can make decisions with enough time to act on them.
View client outcomes →A USEFUL FIRST CONVERSATION
Does our intended use and predicate approach support the 510(k) path we are planning?
Which evidence and documentation need to be ready before we commit to the test plan?
Where are the regulatory, engineering, quality, and labeling records telling different stories?
Do we need a full submission partner, a readiness review, or focused senior support?
FREQUENTLY ASKED QUESTIONS
The best time is before the intended use, predicate approach, and testing plan become difficult to change. Support can also be valuable when a program needs a readiness review, additional submission capacity, or help responding to FDA questions.
Yes. Qualira can join an active program to assess the regulatory strategy, identify gaps across the evidence and submission record, strengthen specific sections, or help organize the work required before filing.
No. The evidence needed depends on the device, intended use, technological characteristics, predicate comparison, and the questions that remain after non-clinical testing and other supporting information are considered. A focused strategy helps a team avoid both unsupported assumptions and unnecessary work.
Yes. Effective responses begin with a clear read of the question, the evidence already available, and any work needed to close the underlying gap. Qualira can help the team develop a focused response strategy and keep the technical, regulatory, and quality inputs aligned.
That is an important finding, not a failure. If the predicate approach or intended use does not support a defensible 510(k), Qualira can help the team assess alternatives such as a different predicate strategy, a narrower claim set, a Pre-Submission, or another regulatory route.
TALK WITH QUALIRA